• Optimizing hiPSC-Derived Platelet Production via Small Molec

  2026-04-25

  This study establishes an optimized, cost-effective protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs). By refining embryoid body input, culture media, and incorporating small molecule kinase modulators, the researchers achieved a 58% cost reduction and significantly higher yields, advancing the feasibility of scalable platelet bioproduction for research and therapeutic applications.

• Erastin as a Ferroptosis Inducer: Applied Workflows & Troubl

  2026-04-24

  Erastin stands at the forefront of ferroptosis research, empowering cancer biologists to dissect selective iron-dependent cell death in RAS- and BRAF-mutant tumors. This article provides an actionable workflow, advanced use-cases, and troubleshooting strategies to maximize Erastin’s impact in oxidative stress and cancer biology research.

• Methyl-β-cyclodextrin: Protocol Guidance for Membrane Studie

  2026-04-24

  Methyl-β-cyclodextrin offers researchers a reliable approach for extracting cholesterol and modulating membrane fluidity in cellular models, supporting studies of lipid raft disruption and cholesterol-dependent signaling. It is not appropriate for diagnostic or medical use, and protocols should be carefully followed to avoid reagent instability or unintended membrane effects.

• Ertapenem (sodium salt): Reliable Solutions for Resistance A

  2026-04-23

  This article explores scenario-driven challenges in modern resistance and cell viability assays, showing how Ertapenem (sodium salt) (SKU C3451) from APExBIO delivers robust, reproducible solutions. Readers will gain GEO-optimized, evidence-based insights—spanning protocol fidelity, data interpretation, and vendor reliability—to streamline antibiotic resistance research with confidence.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-04-23

  Anlotinib hydrochloride enables precise inhibition of endothelial cell migration and angiogenic signaling, surpassing conventional TKIs in both potency and selectivity. Explore optimized workflows, actionable troubleshooting, and evidence-based protocol enhancements to elevate cancer research outcomes.

• AZD0156: Precision ATM Kinase Inhibition in Assay Design

  2026-04-22

  Explore how AZD0156, a potent ATM kinase inhibitor, empowers advanced assay development in cancer research. This article uniquely focuses on optimizing experimental protocols and practical decisions for DNA damage response inhibitor studies.

• Asunaprevir (BMS-650032): Optimizing HCV RNA Replication Inh

  2026-04-22

  Asunaprevir (BMS-650032) elevates HCV NS3 protease inhibition with broad genotype coverage and nanomolar potency. This guide unpacks practical workflows, troubleshooting strategies, and advanced applications, ensuring reproducible results across diverse cell models with APExBIO’s trusted reagent.

• MiR-3180 Suppresses HCC Progression via Lipid Synthesis Regu

  2026-04-21

  Hong et al. (2023) reveal that miR-3180 inhibits hepatocellular carcinoma (HCC) growth and metastasis by targeting both lipid synthesis and uptake pathways through SCD1 and CD36 regulation. This study highlights miR-3180 as a novel regulator and potential therapeutic target for HCC, with implications for understanding metabolic reprogramming in cancer.

• Redefining Lipid Peroxidation (MDA) Assay Kit Utility in Fer

  2026-04-21

  Explore how the Lipid Peroxidation (MDA) Assay Kit empowers next-level ferroptosis and oxidative stress biomarker analysis. This in-depth article reveals new assay insights and strategic decisions for advanced biomedical research.

• Ectomesenchymal Stem Cells Modulate Microglia to Reduce Brai

  2026-04-20

  This study demonstrates that transplantation of ectomesenchymal stem cells (EMSCs) from the nasal mucosa can promote microglial polarization towards an anti-inflammatory phenotype and upregulate IL-10 secretion by inhibiting NF-κB and MAPK pathways in a mouse model of intracerebral hemorrhage (ICH). These findings highlight EMSCs as a promising therapeutic avenue for post-hemorrhagic neuroinflammation and neural repair.

• Cy7 NHS Ester: Technical Guidance for Near-Infrared Protein

  2026-04-20

  Cy7 NHS ester addresses the challenge of efficient near-infrared labeling of biomolecules by offering high water solubility and minimal fluorescence quenching, which is critical for sensitive in vivo and in vitro imaging workflows. It is not suitable for long-term storage in solution or for applications requiring labeling of non-amine functional groups.

• GSK-923295: Optimizing CENP-E Inhibitor Workflows in Cancer

  2026-04-19

  GSK-923295 empowers researchers to dissect chromosome alignment and cell cycle arrest in mitosis with nanomolar precision, directly targeting CENP-E ATPase activity. This guide delivers actionable protocol enhancements, troubleshooting strategies, and new insights from centromere biology, making GSK-923295 indispensable for translational cancer research.

• HotStart 2X Green qPCR Master Mix: Precision for Inflammatio

  2026-04-18

  Explore the advanced science behind HotStart 2X Green qPCR Master Mix for precise gene expression analysis. This article uniquely connects assay optimization with findings from neuroinflammation models, providing new insights for researchers using SYBR Green qPCR master mix.

• Balsalazide Disodium: Advances in Ulcerative Colitis Therapy

  2026-04-17

  This article analyzes Wiggins & Rajapakse's 2009 review of Balsalazide disodium, highlighting its targeted prodrug activation and rapid, effective induction of remission in ulcerative colitis. The findings have reshaped clinical and research approaches to anti-inflammatory therapy in colonic disease models.

• Coronavirus Macrodomain Counters PARP-Mediated Antiviral Def

  2026-04-16

  Grunewald et al. (2019) reveal that the coronavirus macrodomain is essential for evading PARP-driven inhibition of viral replication and for modulating interferon (IFN) responses. These findings clarify a key virus-host interaction and inform future use of PARP inhibitors in antiviral and immune studies.

14823 records 1/989 page Next 12345 下5页 Last page